Document is current
Any future updates will be listed below
-
Authors
Rutten, Philip
Mocking, Tim R.
Cloos, Jacqueline
van Wieringen, Wessel N.
Bachas, Costa
-
Funding
Funding for this research was provided by:
Stichting Cancer Center Amsterdam (CCA2020-9-68, CCA2020-9-68, CCA2020-9-68, CCA2020-9-68, CCA2020-9-68)
- License Information
-
More Information
Article History
Received: 15 March 2024
Accepted: 25 September 2025
First Online: 23 October 2025
Declarations
:
: Involvement of human participants was approved by the institutional review boards of Amsterdam UMC (#METC 2023.0883) for in-house participants and Erasmus MC (#MEC-2013-539) for patients in the HOVON-SAKK-132 trial. This research adhered to the Declaration of Helsinki. All individuals provided written consent, and approval was obtained from the ethics committees of the participating institutions.
: Not applicable.
: The authors declare no conflict of interest.
